Receptor-mediated hepatocyte-targeted delivery of primaquine phosphate nanocarboplex using a carbohydrate ligand

Drug Delivery and Translational Research
Vishvesh M Joshi, Padma V Devarajan

Abstract

Primaquine phosphate is a drug of choice for the treatment of malarial relapse. However, poor drug concentration in the hepatocytes and dose-related toxicity pose severe limitations. We report a nanocarboplex of primaquine phosphate by a simple in situ process using dextran sulphate as a carbohydrate polymer and pullulan as an asialoglycoprotein receptor ligand. Our aim was to preferentially enhance accumulation of the nanocarboplex in the hepatocytes. The in situ pullulan-anchored primaquine nanocarboplex was prepared by simple addition of a solution of dextran sulphate and pullulan with stabilizer to a measured quantity of primaquine phosphate in a vial, followed by shaking to obtain the primaquine phosphate nanocarboplex ready for injection. The nanocarboplex was characterized and evaluated in vivo for pharmacokinetics and biodistribution in the rat model. Specific uptake by hepatocytes in the liver was also quantified. Increase in t ½ with significant uptake in the RES organ was observed. More importantly, anchoring pullulan favored high liver uptake and preferential accumulation in the hepatocytes with a hepatocytes/nonparenchymal cells ratio of 75:25. The in situ primaquine phosphate nanocarboplex anchored with pullulan p...Continue Reading

References

Apr 1, 1984·Journal of Pharmaceutical Sciences·A M ClarkJ D McChesney
Aug 1, 1980·Annals of Tropical Medicine and Parasitology·P PirsonF Herman
Jan 1, 1995·Cancer Chemotherapy and Pharmacology·T BogushJ Robert
Feb 22, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·Y KaneoY Yamaguchi
Jun 25, 2003·British Journal of Anaesthesia·F Boer
Jul 28, 2004·Langmuir : the ACS Journal of Surfaces and Colloids·M V KitaevaA A Yaroslavov
Apr 26, 2005·International Journal of Pharmaceutics·D BhadraN K Jain
Sep 6, 2005·International Journal of Pharmaceutics·Annie M Dierling, Zhengrong Cui
Jul 17, 2007·Journal of Controlled Release : Official Journal of the Controlled Release Society·Y TianKam C Tam
Aug 22, 2007·International Journal of Pharmaceutics·Kamalinder K Singh, Sharvani K Vingkar
Oct 29, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Wasiu A OlowuTajudeen G Oyetunji
Feb 6, 2010·Trends in Parasitology·Timothy N C WellsJ Kevin Baird
Sep 22, 2010·International Journal of Pharmaceutics·Swati A GuhagarkarPadma V Devarajan
Apr 19, 2011·Malaria Journal·Lena Hulden, Larry Hulden
May 24, 2011·Journal of Drug Delivery·Ripal GaudanaAshim K Mitra
Dec 14, 2011·International Journal of Nanomedicine·Shaoping SunFude Cui
Mar 15, 2012·International Journal of Pharmaceutics·Sonali V KapsePadma V Devarajan
Aug 21, 2012·Malaria Journal·George K JohnRic N Price
Dec 4, 2012·Advances in Parasitology·G Dennis Shanks
Jul 3, 2013·The Lancet Infectious Diseases·G Dennis Shanks, Nicholas J White

❮ Previous
Next ❯

Citations

Feb 24, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Anisha A D'Souza, Padma V Devarajan
Apr 14, 2016·Drug Delivery and Translational Research·Miloni Thakkar, Brijesh S
Feb 6, 2017·Drug Delivery·Sandhya PranatharthiharanPadma V Devarajan
Oct 17, 2018·Pharmaceutical Research·Sindisiwe MvangoMohammed O Balogun
Jan 27, 2019·Bioengineering & Translational Medicine·Priyanka S JahagirdarPadma V Devarajan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.